了解心力衰竭患者的尿液不坚持:一种混合方法研究
Rebecca Meraz1, Kathryn Osteen1, Jocelyn Mcgee2
1Baylor University Louise Herrington School of Nursing, Dallas, TX, USA.
Chronic illness
|May 28, 2025
概括
许多心力衰竭患者与利尿药不坚持作斗争,由复杂的有意和无意因素混合驱动,包括尊严问题和自决权. 了解这些原因是改善患者护理的关键.
科学领域:
- 心脏病学 心脏病学
- 患者坚持的研究研究.
- 健康心理学 心理健康心理学
背景情况:
- 心力衰竭 (HF) 是重新入院的首要原因.
- 利尿药物治疗对于管理HF症状和预防再入院至关重要.
- 不坚持服用利尿药物是HF管理中的一个重大挑战.
研究的目的:
- 为了量化90天HF重入医院的患者的尿液不坚持.
- 在这个人群中探索尿剂不坚持背后的多方面的原因.
主要方法:
- 融合平行混合方法设计,整合定量和定性数据.
- 使用主观范围的领域的不遵守规模进行定量评估.
- 采用半结构面试,深入探索患者体验的质量.
- 应用描述和回归测试用于定量分析和定性数据的主题分析.
- 通过合并定量和定性发现,开发了元推理.
主要成果:
- 在82名成年参与者中,有61%的参与者表现出尿素不坚持.
- 超推理揭示了不坚持作为一个频谱,不是纯粹的故意或无意的.
- 对失去尊严的恐惧成为导致不遵守的重要因素.
- 尿液不坚持被确定为患者自决的行为.
结论:
- 心力衰竭患者的尿液不坚持是复杂的,涉及有意识和无意识的动机.
- 维护尊严和断言自决似乎是影响药物坚持的关键驱动因素.
- 临床医生和研究人员应该考虑这些心理因素,以改善坚持策略,减少心力衰竭的再入院.
相关概念视频
Heart Failure Drugs: Diuretics
505
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
505
Heart Failure V: Medical Management
34
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
34
Heart Failure VI: Adjunct Therapies
39
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
39
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
526
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
526
Heart Failure VII: Nursing Interventions
147
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
147
Mitral Regurgitation IV: Nursing Management
97
Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
97


